Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ALT
#2708
Altimmune, Inc. Common Stock
4.3
1
-4.01%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-4.01%
Monatliche Änderung
-27.81%
6 month change
+14.02%
Jahresänderung
-31.04%
Vorheriger Schlusskurs
4.4
9
Open
4.3
1
Bid
Ask
Low
4.3
1
High
4.3
1
Volumen
103
Märkte
Aktien
Gesundheitswesen
ALT
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
37.15 M
43.22 M
49.28 M
70.9 M
77.01 M
—
Valuation ratios
Enterprise value
303.14 M
205.62 M
659.13 M
610.7 M
518.34 M
1.37 B
Price to earnings ratio
—
-3.9
-8.64
-6.34
-5.38
-16.15
Price to sales ratio
—
85.74
-10.79 K
1 314.92
25.6 K
72.34 K
Price to cash flow ratio
—
-4.83
-11.72
-7.39
-6.41
-18.7
Price to book ratio
—
1.9
3.96
2.89
4.14
5.79
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.2
-0.44
0.41
0.42
0.68
0.49
Return on equity %
0.22
-0.49
0.46
0.46
0.77
0.57
Return on invested capital %
1 240.11
-1 610.96
1 362.31
2 511.39
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
669.5
-2 197.42
129.03 K
22.52 K
515.86 K
1.81 M
EBITDA margin %
—
—
—
—
—
—
Net margin %
599.2
-2 201.43
124.58 K
20.76 K
475.29 K
1.68 M
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
19.16
11.17
11.31
17.26
13.11
66.58
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.05
0.02
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.01
0.01
0.02
—
—
—
Long term debt to total equity ratio
0.01
0.01
0.02
—
—
—
Per share metrics
Operating cash flow per share
—
-1.9
1.33
1.42
1.12
0.85
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
4.61
3.94
3.72
1.86
8.45
Net current asset value per share
—
4.94
4.11
3.94
1.93
8.72
Tangible book value per share
—
4.52
3.68
3.65
1.74
7.68
Working capital per share
—
4.5
3.75
3.71
1.79
8.19
Book value per share
—
4.82
3.95
3.65
1.74
7.68
Nachrichten
AIM Smarter nomme Christopher Young au poste de directeur commercial
AIM Smarter appoints Christopher Young as chief commercial officer
Obesity stocks slump on Novo’s underwhelming 2026 sales forecast
Obesity stocks slump on Novo's underwhelming 2026 sales forecast
Les actions de Novo Nordisk chutent suite à des prévisions de ventes faibles pour 2026
Les actions de Novo Nordisk chutent suite à des perspectives de ventes faibles pour 2026
Novo Nordisk shares plunge on weak 2026 sales outlook
Altimmune finalise son placement privé de 75 millions $
Altimmune closes $75 million registered direct offering
Altimmune: Why Breakthrough Status Isn't A 'Buy' Signal Just Yet (NASDAQ:ALT)
Altimmune (ALT) Shares Slide On $75 Million Stock Offering - Altimmune (NASDAQ:ALT)
L’action d’Altimmune chute après l’annonce d’une offre directe de 75 millions $